Report Scope:
This research study analyzes the GI diagnostics and therapeutics market, offers revenue forecasts, assesses future trends and provides strategic recommendations for the success of market participants. The scope of the study is global. This report estimates market data for 2022 (the base year) and forecasts for 2023 through 2028. Figures for 2023 are estimated, except where actual results have been reported. This report includes forecasts by product type and region from 2023 through 2028.

Report Includes:

  • 43 data tables and 66 additional tables
  • An overview of the global markets for gastrointestinal disease (GI) therapeutics and diagnostics.
  • Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028.
  • Discussion of the current and future market potential for GI therapeutics and diagnostics, along with an analysis of the competitive environment, regulatory scenario, and technological advances.
  • Estimate of the market size and revenue forecast for the global market, and corresponding market share analysis by diagnostics type, end user and region.
  • Facts and figures pertaining to the major market dynamics, opportunities and deterrents, emerging technologies, future prospects and the impacts of macroeconomic variables.
  • A look at the GI therapeutics and diagnostic options currently available as well as potential products and classes of products that are likely to have an impact.
  • Discussion of sustainability trends and ESG developments, with an emphasis on consumer attitudes, analysis of companies’ ESG scores, and the ESG practices followed by leading companies.
  • Information pertaining to the recent developments and emerging technologies in the market.
  • Review of current and potential treatment options and their impact on this market growth.
  • A look at the industry structure, competitive aspects of each product segment, increasing investment in R&D, market development strategies, and company value share analysis.
  • An analysis of the competitive landscape based on recent developments and segmental revenues.
  • Profiles of the major global players, including Takeda Pharmaceutical Co. Ltd., Johnson & Johnson Services Inc., AbbVie Inc., Sanofi, Bristol-Myers Squibb Co., and F. Hoffmann-La Roche Ltd.